104668-15-7 Usage
Description
3-FORMYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is a chemical compound characterized by the molecular formula C16H19NO3. It is a tert-butyl ester derivative of 3-formyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid, known for its unique chemical properties that make it a valuable asset in the fields of organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
3-FORMYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is used as an intermediate in the synthesis of various organic compounds. Its unique structure allows for the creation of a wide range of chemical entities, making it a versatile building block in the development of new molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-FORMYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a key component in the development of new drugs and pharmaceutical products. Its potential biological and pharmacological activities contribute to the exploration of novel therapeutic agents, particularly in the context of drug discovery and design.
Used in Biochemical Research:
3-FORMYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is also utilized in biochemical studies to investigate various biochemical processes and pathways. Its presence in these studies can provide insights into the mechanisms of action and potential interactions with biological systems, furthering our understanding of its applications in medicine and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 104668-15-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,6,6 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 104668-15:
(8*1)+(7*0)+(6*4)+(5*6)+(4*6)+(3*8)+(2*1)+(1*5)=117
117 % 10 = 7
So 104668-15-7 is a valid CAS Registry Number.
104668-15-7Relevant articles and documents
TIPP: A Highly Potent and Stable Pseudopeptide δ Opioid Receptor Antagonist with Extraordinary δ Selectivity
Schiller, Peter W.,Weltrowska, Grazyna,Nguyen, Thi M.-D.,Wilkes, Brian C.,Chung, Nga N.,Lemieux, Carole
, p. 3182 - 3187 (1993)
Pseudopeptide analogues of the δ opioid antagonists H-Tyr-Tic-Phe-Phe-OH (TIPP) and H-Tyr-Tic-Phe-OH (TIP) containing a reduced peptide bond between the Tic2 and Phe3 residues were synthesized.The two compounds, H-Tyr-TicψPhe-
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1
Lu, Jian,Bart, Aaron G.,Wu, Qian,Criscione, Kevin R.,McLeish, Michael J.,Scott, Emily E.,Grunewald, Gary L.
, p. 13878 - 13898 (2020/12/02)
The enzyme phenylethanolamine N-methyltransferase (PNMT, EC 2.1.1.28) catalyzes the final step in the biosynthesis of epinephrine and is a potential drug target, primarily for the control of hypertension. Unfortunately, many potent PNMT inhibitors also po
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
-
Page/Page column 58, (2010/02/06)
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction.